M&T Bank’s BioTelemetry, Inc. BEAT Stock Holding History

M&T Bank’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,475	Closed	-$1.19M	–	1775
2020 Q4	$1.19M	Sell	16,475 -2,705	-14%	-$142K	0.01%	712
2020 Q3	$874K	Buy	19,180 +4,034	+27%	+$169K	﹤0.01%	756
2020 Q2	$685K	Buy	15,146 +843	+6%	+$37.8K	﹤0.01%	823
2020 Q1	$550K	Buy	14,303 +4,717	+49%	+$217K	﹤0.01%	874
2019 Q4	$444K	Buy	9,586 +656	+7%	+$28.4K	﹤0.01%	905
2019 Q3	$364K	Buy	8,930 +1,451	+19%	+$62.6K	﹤0.01%	1088
2019 Q2	$360K	Buy	7,479 +4,150	+125%	+$218K	﹤0.01%	1131
2019 Q1	$208K	Buy	+3,329	New	+$229K	﹤0.01%	1397
2018 Q4	–	Sell	-3,501	Closed	-$225K	–	1619
2018 Q3	$225K	Buy	+3,501	New	+$195K	﹤0.01%	1379
2017 Q4	–	Sell	-6,256	Closed	-$207K	–	1714
2017 Q3	$207K	Buy	+6,256	New	+$217K	﹤0.01%	1407

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

M&T Bank's BEAT Position: Q1 2021 in Review

M&T Bank sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 16,475 shares — an estimated $1.19M sold.

M&T Bank first reported a position in BEAT in Q3 2017 and held it in 10 quarters. The position peaked at $1.19M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

M&T Bank reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
M&T Bank sold 16,475 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.19M.
M&T Bank first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 10 quarters.
M&T Bank's BioTelemetry, Inc. position peaked at $1.19M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on M&T Bank's 13F filing for Q1 2021, filed 6 May 2021.